Cargando…

Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002

OBJECTIVE: To provide an estimate of age-specific incidence rate of physician-diagnosed systemic lupus erythematosus (SLE) for German men and women. METHODS: The age-specific and sex-specific prevalence of diagnosed SLE in claims data is used to estimate the incidence in the German male and female p...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinks, Ralph, Hoyer, Annika, Weber, Sergej, Fischer-Betz, Rebecca, Sander, Oliver, Richter, Jutta G, Chehab, Gamal, Schneider, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133401/
https://www.ncbi.nlm.nih.gov/pubmed/27933200
http://dx.doi.org/10.1136/lupus-2016-000181
_version_ 1782471254254551040
author Brinks, Ralph
Hoyer, Annika
Weber, Sergej
Fischer-Betz, Rebecca
Sander, Oliver
Richter, Jutta G
Chehab, Gamal
Schneider, Matthias
author_facet Brinks, Ralph
Hoyer, Annika
Weber, Sergej
Fischer-Betz, Rebecca
Sander, Oliver
Richter, Jutta G
Chehab, Gamal
Schneider, Matthias
author_sort Brinks, Ralph
collection PubMed
description OBJECTIVE: To provide an estimate of age-specific incidence rate of physician-diagnosed systemic lupus erythematosus (SLE) for German men and women. METHODS: The age-specific and sex-specific prevalence of diagnosed SLE in claims data is used to estimate the incidence in the German male and female population. The claims data set stems from a representative sample of the statutory health insurance in 2002 and comprises 2.3 million people. The statutory health insurance covers >85% of the German population. RESULTS: The estimated incidence rates are 0.9 (95% CI 0.7 to 1.1) per 100 000 person-years for men and 1.9 (95% CI 1.7 to 2.2) per 100 000 person-years for women. The age-specific incidence rate of SLE in the male population has a maximum of 2.2 (95% CI 1.0 to 3.4) per 100 000 person-years at the age of 65–70 years. In women, the incidence is peaking at the rate of 3.6 (95% CI 2.9 to 4.3) cases per 100 000 person-years at the age of 20–25 years, but has a second local maximum (2.6, 95% CI 1.5 to 3.8) at menopausal age. CONCLUSIONS: For the first time, representative data on the incidence of SLE in Germany are provided. The estimated incidence rates of SLE for men and women in Germany are at the lower end of other estimates from comparable European countries.
format Online
Article
Text
id pubmed-5133401
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51334012016-12-08 Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002 Brinks, Ralph Hoyer, Annika Weber, Sergej Fischer-Betz, Rebecca Sander, Oliver Richter, Jutta G Chehab, Gamal Schneider, Matthias Lupus Sci Med Brief Communication OBJECTIVE: To provide an estimate of age-specific incidence rate of physician-diagnosed systemic lupus erythematosus (SLE) for German men and women. METHODS: The age-specific and sex-specific prevalence of diagnosed SLE in claims data is used to estimate the incidence in the German male and female population. The claims data set stems from a representative sample of the statutory health insurance in 2002 and comprises 2.3 million people. The statutory health insurance covers >85% of the German population. RESULTS: The estimated incidence rates are 0.9 (95% CI 0.7 to 1.1) per 100 000 person-years for men and 1.9 (95% CI 1.7 to 2.2) per 100 000 person-years for women. The age-specific incidence rate of SLE in the male population has a maximum of 2.2 (95% CI 1.0 to 3.4) per 100 000 person-years at the age of 65–70 years. In women, the incidence is peaking at the rate of 3.6 (95% CI 2.9 to 4.3) cases per 100 000 person-years at the age of 20–25 years, but has a second local maximum (2.6, 95% CI 1.5 to 3.8) at menopausal age. CONCLUSIONS: For the first time, representative data on the incidence of SLE in Germany are provided. The estimated incidence rates of SLE for men and women in Germany are at the lower end of other estimates from comparable European countries. BMJ Publishing Group 2016-11-25 /pmc/articles/PMC5133401/ /pubmed/27933200 http://dx.doi.org/10.1136/lupus-2016-000181 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Brief Communication
Brinks, Ralph
Hoyer, Annika
Weber, Sergej
Fischer-Betz, Rebecca
Sander, Oliver
Richter, Jutta G
Chehab, Gamal
Schneider, Matthias
Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title_full Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title_fullStr Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title_full_unstemmed Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title_short Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
title_sort age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the german statutory health insurance 2002
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133401/
https://www.ncbi.nlm.nih.gov/pubmed/27933200
http://dx.doi.org/10.1136/lupus-2016-000181
work_keys_str_mv AT brinksralph agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT hoyerannika agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT webersergej agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT fischerbetzrebecca agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT sanderoliver agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT richterjuttag agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT chehabgamal agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002
AT schneidermatthias agespecificandsexspecificincidenceofsystemiclupuserythematosusanestimatefromcrosssectionalclaimsdataof23millionpeopleinthegermanstatutoryhealthinsurance2002